Antimicrobial effect of halocidin-derived peptide in a mouse model of Listeria infection

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 11, 2007, Pages 4148-4156

  Woong, Sik Jang ^a   Lee, Sang Chul ^b   Young, Shin Lee ^a   Yong, Pyo Shin ^a   Kyoung, Hwa Shin ^a   Boo, Hee Sung ^b   Kim, Byung S ^b   Soo, Han Lee ^c   In, Hee Lee ^a  

^a Hoseo University   (South Korea)

^b University of Ulsan   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HALOCIDIN; MELITTIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN ANTIBODY; PROTEIN KHA1; PROTEIN KHA1 ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL SURVIVAL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; GRAM POSITIVE BACTERIUM; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; INOCULATION; LISTERIA; LISTERIOSIS; LIVER CELL; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SPLEEN CELL; SYSTEMIC DISEASE; VALIDATION PROCESS;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMOLYSIS; HUMANS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; LIVER; MALE; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; PEPTIDES; SPLEEN; TIME FACTORS;

EID: 35848970108     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00635-07     Document Type: Article

References (28)

1. Bradshaw, J. 2003. Cationic antimicrobial peptides: issues for potential clinical use. BioDrugs 17:233-240.
2. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Czuprynski, C. J., N. G. Faith, and H. Steinberg. 2003. A/J mice are susceptible and C57BL/6 mice are resistant to Listeria monocytogenes infection by intragastric inoculation. Infect. Immun. 71:682-689.
4. Deslouches, B., K. Islam, J. K. Craigo, S. M. Paranjape, R. C. Montelaro, and T. A. Mietzner. 2005. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications. Antimicrob. Agents Chemother. 49:3208-3216.
5. Fjell, C. D., R. E. Hancock, and A. Cherkasov. 2007. AMPer: a database and an automated discovery tool for antimicrobial peptides. Bioinformatics 23:1148-1155.
6. Frecer, V., B. Ho, and J. L. Ding. 2004. De novo design of potent antimicrobial peptides. Antimicrob. Agents Chemother. 48:3349-3357.
7. Gregory, S. H., A. J. Sagnimeni, and E. J. Wing. 1996. Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils. J. Immunol. 157:2514-2520.
8. Hamamoto, K., Y. Kida, Y. Zhang, T. Shimizu, and K. Kuwano. 2002. Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions. Microbiol. Immunol. 46:741-749.
9. Hamon, M., H. Bierne, and P. Cossart. 2006. Listeria monocytogenes: a multifaceted model. Nat. Rev. Immunol. 4:423-434.
10. Hancock, R. E., and H. G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557.
11. Hoefel, D., W. L. Grooby, P. T. Monis, S. Andrews, and C. P. Saint. 2003. Enumeration of water-borne bacteria using viability assays and flow cytometry: a comparison to culture-based techniques. J. Microbiol. Methods 55:585-597.
12. Jang, W. S., C. H. Kim, M. S. Kang, H. J. Chae, S. M. Son, S. J. Seo, and I. H. Lee. 2005. cDNA cloning of halocidin and a new antimicrobial peptide derived from the N-terminus of Ci-META4. Peptides 26:2360-2367.
13. Jang, W. S., C. H. Kim, K. N. Kim, S. Y. Park, J. H. Lee, S. M. Son, and I. H. Lee. 2003. Biological activities of synthetic analogs of halocidin, an antimicrobial peptide from the tunicate Halocynthia aurantium. Antimicrob. Agents Chemother. 47:2481-2486.
14. Jang, W. S., H. K. Kim, K. Y. Lee, S. A. Kim, Y. S. Han, and I. H. Lee. 2006. Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium. FEBS Lett. 580:1490-1496.
15. Jang, W. S., K. N. Kim, Y. S. Lee, M. H. Nam, and I. H. Lee. 2002. Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. FEBS Lett. 521:81-86.
16. Levy, O. 2000. Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 96:2664-2672.
17. Lopez, F. E., P. A. Vincent, A. M. Zenoff, R. A. Salomon, and R. N. Farias. 2007. Efficacy of microcin J25 in biomatrices and in a mouse model of Salmonella infection. J. Antimicrob. Chemother. 59:676-680.
18. Marco, A. J., N. Prats, J. A. Ramos, V. Briones, M. Blanco, L. Dominguez, and M. Domingo. 1992. A microbiological, histopathological and immunohistological study of the intragastric inoculation of Listeria monocytogenes in mice. J. Comp. Pathol. 107:1-9.
19. Munoz, A., B. Lopez-Garcia, E. Perez-Paya, and J. F. Marcos. 2007. Antimicrobial properties of derivatives of the cationic tryptophan-rich hexapeptide PAF26. Biochem. Biophys. Res. Commun. 354:172-177.
20. Nordahl, E. A., V. Rydengard, M. Morgelin, and A. Schmidtchen. 2005. Domain 5 of high molecular weight kininogen is antibacterial. J. Biol. Chem. 280:34832-34839.
21. Pizarro-Cerda, J., and P. Cossart. 2006. Subversion of cellular functions by Listeria monocytogenes. J. Pathol. 208:215-223.
22. Reddy, K. V., R. D. Yedery, and C. Aranha. 2004. Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents 24:536-547.
23. Seebah, S., A. Suresh, S. Zhuo, Y. H. Choong, H. Chua, D. Chuon, R. Beuerman, and C. Verma. 2007. Defensins knowledgebase: a manually curated database and information source focused on the defensins family of antimicrobial peptides. Nucleic Acids Res. 35:D265-D268.
24. Shai, Y. 2002. Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236-248.
25. Steinberg, D. A., and R. I. Lehrer. 1997. Designer assays for antimicrobial peptides. Disputing the "one-size-fits-all" theory. Methods Mol. Biol. 78:169-186.
26. Wu, M., E. Maier, R. Benz, and R. E. Hancock. 1999. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 38:7235-7242.
27. Yamada, K., S. S. Shinoda, H. Oku, K. Komagoe, T. Katsu, and R. Katakai. 2006. Synthesis of low-hemolytic antimicrobial dehydropeptides based on gramicidin S. J. Med. Chem. 49:7592-7595.
28. Zhang, L., and T. J. Falla. 2006. Antimicrobial peptides: therapeutic potential. Expert Opin. Pharmacother. 7:653-663.